Results 241 to 250 of about 155,912 (356)

Ear, Nose, and Throat Foreign Bodies in Children: A Retrospective Study. [PDF]

Children (Basel), 2022
Kwon B, Choi Y, Kim SK, Hong SJ, Kim YB, Hong SM.   +5 more
europepmc   +1 more source

Hospitals for Diseases of the Throat, Nose, and Ear [PDF]

, 1901

openalex   +1 more source

The Performance of Automatic Speaking Valves and Fixation Devices Enabling Hands‐Free Speech Following Total Laryngectomy—A Systematic Review

Head &Neck, EarlyView.
ABSTRACT Background The percentage of daily automatic speaking valve use (AU) in laryngectomized patients has remained at ~25% since their invention. To increase this percentage, understanding the performance of existent devices is essential. Therefore, we reviewed studies reporting AU, fixation device lifetime (FDL), compliance, and voice and speech ...
Max J. Dullaart, Sebastiaan R. de Vreugd, Maartje Leemans, Rob van Son, Arjan Malekzadeh, Maarten J. A. van Alphen, Lisette van der Molen, Michiel W. M. van den Brekel, Luc H. E. Karssemakers, Richard Dirven   +9 more
wiley   +1 more source

Speech and language therapist-led clinics for low-risk suspected head and neck cancer referrals: A qualitative study of ear, nose and throat surgeons' views. [PDF]

Int J Lang Commun Disord
Occomore-Kent LC, Hardman JC, Roe JWG, Bradley P, Carding PN, Patterson JM.   +5 more
europepmc   +1 more source

Simulation-based training in ear, nose and throat skills and emergencies. [PDF]

Braz J Otorhinolaryngol, 2023
Mk G, Saldanha M, Bhat VS, A R, Vincent MJ, Ravikumar A.   +5 more
europepmc   +1 more source

Diseases of the Ear, Throat and Nose [PDF]

, 1938

openalex   +1 more source

CRISPR Screens Identify PIK3C2A as a Novel Mediator of EGFR Inhibitor Resistance in Head and Neck Squamous Cell Carcinoma

Head &Neck, EarlyView.
ABSTRACT Background Head and neck squamous cell carcinoma (HNSCC) is a malignancy with poor prognosis and survival. While epidermal growth factor receptor (EGFR) is a known driver of HNSCC, EGFR inhibitors show limited efficacy as monotherapies, suggesting that effective combination therapies are needed.
Jiayu Wang, Megan L. Ludwig, Aditi Kulkarni, Andrew C. Birkeland, Nicole L. Michmerhuizen, Elizabeth Gensterblum‐Miller, Jingyi Zhai, Hui Jiang, Paul Swiecicki, Marisa Buchakjian, Molly Heft Neal, Steven B. Chinn, Matthew E. Spector, J. Chad Brenner   +13 more
wiley   +1 more source

Nalbuphine's Hemodynamic Impact in Ear, Nose, and Throat (ENT) Surgeries: A Comprehensive Review. [PDF]

Cureus
Shah D, Sen J.
europepmc   +1 more source

Letter to the editor about the article: "The psychological impact of COVID-19 on ear, nose and throat (ENT) specialists". [PDF]

Ir J Med Sci, 2023
Ko TK.
europepmc   +1 more source

Merkel Cell Carcinoma: Evolving Therapeutics, Continued Challenges

Head &Neck, EarlyView.
ABSTRACT Background Merkel Cell Carcinoma (MCC) is a rare, aggressive neuroendocrine malignancy with rising incidence, influenced by ultraviolet (UV) radiation and Merkel cell polyomavirus (MCPyV). Methods This review summarizes recent advances in MCC management, based on an analysis of current literature, focusing on immune checkpoint inhibitors (ICIs)
Hunter A. Holley, Maria Lyons, Barry O'Sullivan, Neville Shine, Robbie Woods, Orla McArdle, James Paul O'Neill   +6 more
wiley   +1 more source